Remarkably, analyses of MDK receptor-expressing CD8 cells (ITGA4, ITGB1, NCL) showed the opposite trend, with an increase in dysfunctional and reduction in the proliferative (tumor-targeting) populations (Fig. 6h and Supplementary Fig. 6p). The gene discussed is CD8A; the disease is neoplasm.